[Federal Register Volume 75, Number 76 (Wednesday, April 21, 2010)]
[Notices]
[Page 20869]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-9158]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: NRC will convene a meeting of the Advisory Committee on the 
Medical Uses of Isotopes (ACMUI) on May 24-25, 2010. A sample of agenda 
items to be discussed during the public session includes: (1) Updates 
on 10 Code of Federal Regulations (CFR) Parts 35 and 37 rulemakings; 
(2) information on the issue of patient release following 
administration of iodine 131; (3) updates on the medical isotope 
shortage; (4) updates on the prostate brachytherapy medical events that 
occurred at the Veteran's Affairs Medical Center in Philadelphia; (5) a 
subcommittee report on permanent implant brachytherapy; (6) a 
discussion on safety culture in medical practices; (7) an update on the 
status of the technical basis to support Part 35 rulemaking addressing 
the issues of grandfathering certified medical physicists; (8) 
information on the International Atomic Energy Agency's revision to 
Draft Safety Requirements DS379; (9) a subcommittee report on byproduct 
material events for fiscal year 2010; and (10) an issue regarding 
signatures for post-implant written directives for yttrium 90 
microspheres procedures. A copy of the agenda will be available at 
http://www.nrc.gov/reading-rm/doc-collections/acmui/agenda or by e-
mailing Ms. Ashley Cockerham at the contact information below.
    Purpose: Discuss issues related to 10 CFR Part 35 Medical Use of 
Byproduct Material.
    Date and Time for Closed Session: May 24, 2010, from 8 a.m. to 10 
a.m. This session will be closed so that ACMUI members can enroll for 
new badges.
    Date and Time for Open Sessions: May 24, 2010 from 10 a.m. to 4 
p.m. and May 25, 2010, from 8 a.m. to 12:30 p.m.
    Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two 
White Flint North Building, Room T2-B3, 11545 Rockville Pike, 
Rockville, Maryland 20852.
    Public Participation: Any member of the public who wishes to 
participate in the meeting in person or via phone should contact Ms. 
Cockerham using the information below.
    Contact Information: Ashley M. Cockerham, e-mail: 
[email protected], telephone: (240) 888-7129.

Conduct of the Meeting

    Leon S. Malmud, M.D., will chair the meeting. Dr. Malmud will 
conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Cockerham at the contact information listed 
above. All submittals must be received by May 14, 2010, and must 
pertain to the topic on the agenda for the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting, at the discretion of the Chairman.
    3. The draft transcript will be available on ACMUI's Web site 
(http://www.nrc.gov/reading-rm/doc-collections/acmui/tr/) on or about 
June 25, 2010. A meeting summary will be available on ACMUI's Web site 
(http://www.nrc.gov/reading-rm/doc-collections/acmui/meeting-summaries/
) on or about July 8, 2010.
    4. Persons who require special services, such as those for the 
hearing impaired, should notify Ms. Cockerham of their planned 
attendance.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in Title 
10, U.S. Code of Federal Regulations, Part 7.

    Dated: April 15, 2010.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2010-9158 Filed 4-20-10; 8:45 am]
BILLING CODE P